256抗甲状腺药物肝损伤临床诊治进展

doi:10.3969/j.issn.1672-5069.2017.02.003

Abstract

Wang Yuxia，Du Jian.. Diagnostic and therapeutic progress in anti-thyroid drug -induced liver injury[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 135-138.

[1] David S，Cooper MD. Antithyroid drugs. N Engl J Med，1984，311（21）:1353-1362.
[2] Bhuyan AK，Sarma D，Kaimal Saikia U，et al. Grave's disease with severe hepatic dysfunction:A diagnostic and therapeutic challenge. Case Rep Med，2014，2014:790458.
[3] Woeber KA. Methimazole-induced hepatotoxicity. Endocr Pract，2002，8（3）:222-224.
[4] Mathew J，Sundrarajan RS，Gomadam S. Anti-thyroid drugs in pediatric Graves' disease. Indian J Endocrinol Metab，2015，19（3）:340-346.
[5] Shen C，Zhao CY，Liu F，et al. Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot:case report. BMC Gastroenterol，2010，10:93.
[6] Jeon SJ，Kim TY，Lee SH，et al. A case report of methimazole-induced acute liver failure successfully treated with liver transplantation. Kor J Med，2012，83（3）:363-368.
[7] Jie EL，Ye AK，Kim LK，et al. A case of acute liver failure associated with methimazole in patient with underlying liver disease. Soonchunhyang Med Sci，2014，20（2）:195-200.
[8] Zou H，Jin L，Wang LR，et al. Methimazole-induced cholestatic hepatitis:two cases report and literature review. Oncotarget，2016，7（4）:5088-5091.
[9] Wang MT，Lee WJ，Huang TY，et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients:a population-based cohort study. Br J Clin Pharmacol，2014，78（3）:619-629.
[10] Yang J，Li LF，Xu Q，et al. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China. Thyroid，2015，25（3）:278-283.
[11] Rivkees SA，Mattison DR. Ending propylthiouracil-induced liver failure in children. N Engl J Med，2009，360（15）:1574-1575.
[12] Malozowski S，Chiesa A. Propylthiouracil-induced hepatotoxicity and death. Hopefully，never more. J Clin Endocrinol Metab，2010，95（7）:3161-3163.
[13] Yang J，Zhang J，Xu Q，et al. Unusual synchronous methimazole-induced agranulocytosis and severe hepatotoxicity in patient with hyperthyroidism:A case report and review of the literature. Int J Endocrinol，2015，2015:934726.
[14] Heidari R，Niknahad H，Jamshidzadeh A.et al. Factors affecting drug-induced liver injury:antithyroid drugs as instances. Clin Mol Hepatol，2014，20（3）:237-248.
[15] Zhu H，Zhang Z，Wang H，et al. The efficacy and safety of lithium carbonate in combination with radioactive iodine therapy of hyperthyroidism:A meta-analysis and systematic review. Int J Clin Exp Med，2016，9（7）:12721-12728.
[16] Kobayashi M，Higuchi S，Ide M，et al. Th2 cytokine-mediated methimazole-induced acute liver injury in mice. J Appl Toxicol，2012，32（10）:823-833.
[17] Cooper DS.Antithyroid drugs. N Engl J Med，2005，352（9）:905-917.
[18] Mizutani T，Yoshida K，Murakami M，et al. Evidence for the involvement of N-methylthiourea，a ring cleavage metabolite，in the hepatotoxicity of methimazole in glutathione-depleted mice:structure-toxicity and metabolic studies. Chem Res Toxicol，2000，13（3）:170-176.
[19] Heidari R，Babaei H，Eghbal M. Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes. Drug Chem Toxicol，2013，36（4）:403-411.
[20] Heidari R，Babaei H，Roshangar L，et al. Effects of enzyme induction and/or glutathione depletion on methimazole-induced hepatotoxicity in mice and the protective role of N-acetylcysteine. Adv Pharm Bull，2014，4（1）:21-28.
[21] Akai S，Uematsu Y，Tsuneyama K，et al. Kupffer cell-mediated exacerbation of methimazole-induced acute liver injury in rats. J Appl Toxicol，2016，36（5）:702-715.
[22] Heidari R，Niknahad H，Jamshidzadeh A，et al. Factors affecting drug-induced liver injury:antithyroid drugs as instances. Clin Mol Hepatol，2014，20（3）:237-248.
[23] Karras S，Memi E，Kintiraki E，et al. Pathogenesis of propylthiouracil-related hepatotoxicity in children:present concepts. J Pediatr Endocrinol Metab，2012，25（7-8）:623-630.
[24] Kariya K，Sawahata T，Okuno S，et al. Inhibition of hepatic glutathione transferases by propylthiouracil and its metabolites. Biochem Pharmacol，1986，35（9）:1475-147.
[25] 齐艳霞. 甲状腺功能亢进症患者服用抗甲状腺药物出现肝损害的病例分析. 中国现代药物应用，2013，7（23）:156-157.
[26] Beniehou C. Criteria of drug induced liver disorder，Report of international consensus meeting.J He Patol，1990，11（2）:272-276.
[27] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南（2015年版）. 实用肝脏病杂志，2017，20（2）:Ⅰ—ⅩⅧ.
[28] 沈芸，薛海波. 抗甲状腺药物治疗甲状腺功能亢进合并慢性乙型肝炎的疗效及安全性. 中国现代医生，2015，10（9）:83-87.
[29] Ross DS，Burch HB，Cooper DS，et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid，2016 26（10）:1343-1421.
[30] Bahn RS，Burch HB，Cooper DS，et al. Hyperthyroidism and other causes of thyrotoxicosis:management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract，2011，17（3）:456-520.

Diagnostic and therapeutic progress in anti-thyroid drug -induced liver injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[2]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[3]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[4]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[5]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[6]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[7]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[8]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[9]	Wei Lujia, Li Qingxiang, Ji Qingwei.. Clinical features of amiodarone-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 424-426.
[10]	Yu Hongxing Chen Ying Liu Zipeng, et al.. Comparison of ultrasound-guided percutaneous laser ablation and radiofrequency ablation for the treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 320-323.
[11]	Zhang Dai，Wang Bingyuan.. Novel medicines, new members of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 129-131.
[12]	Zheng Kai，Li Hai.. Hepatotoxicity of lipid-lowering agents [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 139-141.
[13]	Zhou Xueshi，Yin Cuilan，Lu Zhonghua，et al.. Drug-induced liver injury：a report of two cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 250-251.
[14]	Lei Wei，Wang Dandan，Ge Guangb，et al.. Serum biomarkers of liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 252-254.
[15]	Hou Chunyan, Yang Yongfeng.. Antiviral therapy for chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 124-128.